Inspire Investing LLC increased its holdings in shares of Surgery Partners, Inc. (NASDAQ:SGRY – Free Report) by 47.5% during the fourth quarter, Holdings Channel.com reports. The fund owned 19,034 shares of the company’s stock after buying an additional 6,131 shares during the period. Inspire Investing LLC’s holdings in Surgery Partners were worth $403,000 at the end of the most recent reporting period.
Other institutional investors have also recently added to or reduced their stakes in the company. King Street Capital Management L.P. purchased a new stake in Surgery Partners during the 3rd quarter valued at about $46,748,000. Janus Henderson Group PLC boosted its position in shares of Surgery Partners by 27.5% during the third quarter. Janus Henderson Group PLC now owns 5,497,368 shares of the company’s stock worth $177,235,000 after buying an additional 1,184,450 shares during the period. Victory Capital Management Inc. grew its position in Surgery Partners by 140.4% in the 3rd quarter. Victory Capital Management Inc. now owns 1,330,399 shares of the company’s stock valued at $42,892,000 after acquiring an additional 777,038 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in Surgery Partners by 26.7% during the 2nd quarter. Dimensional Fund Advisors LP now owns 2,801,091 shares of the company’s stock worth $66,643,000 after buying an additional 589,499 shares during the period. Finally, FMR LLC boosted its holdings in Surgery Partners by 3.1% in the third quarter. FMR LLC now owns 18,311,867 shares of the company’s stock valued at $590,375,000 after purchasing an additional 546,869 shares during the period.
Surgery Partners Price Performance
SGRY stock opened at $20.32 on Friday. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. Surgery Partners, Inc. has a 1 year low of $19.50 and a 1 year high of $35.29. The stock’s 50 day moving average price is $21.40 and its 200 day moving average price is $27.10. The firm has a market cap of $2.58 billion, a P/E ratio of -42.33, a PEG ratio of 14.10 and a beta of 2.58.
Analysts Set New Price Targets
SGRY has been the topic of a number of analyst reports. Royal Bank of Canada reduced their price objective on shares of Surgery Partners from $49.00 to $35.00 and set an “outperform” rating on the stock in a report on Wednesday, November 20th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $43.00 target price on shares of Surgery Partners in a report on Friday, October 4th. UBS Group initiated coverage on Surgery Partners in a research note on Monday, October 14th. They set a “buy” rating and a $38.00 price objective for the company. Bank of America started coverage on shares of Surgery Partners in a report on Monday, December 16th. They issued a “buy” rating and a $30.00 target price on the stock. Finally, Macquarie restated an “outperform” rating and issued a $34.00 price target on shares of Surgery Partners in a research note on Tuesday, November 19th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $36.56.
View Our Latest Report on Surgery Partners
Surgery Partners Company Profile
Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
Recommended Stories
- Five stocks we like better than Surgery Partners
- How to Capture the Benefits of Dividend Increases
- Bloom Energy: Powering the Future With Decentralized Energy
- How to Invest in Biotech Stocks
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- Upcoming IPO Stock Lockup Period, Explained
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Want to see what other hedge funds are holding SGRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Surgery Partners, Inc. (NASDAQ:SGRY – Free Report).
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.